Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Old drugs are often used for new, different medical purposes in endocrine pharmacology.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

A dietary supplement with Boswellia serrata, Curcuma longa, and Vitis vinifera showed potential improvement in hair health for telogen effluvium patients, but more research is needed.

Hyperpigmentation is common in pregnancy and may not fully fade after birth; melasma, also frequent, can persist but has limited treatment options during pregnancy.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Combining microneedling with Minoxidil and Finasteride greatly improves hair growth and reduces hair loss in men.

D-004 may be a natural alternative to finasteride for treating enlarged prostate and male baldness.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Miliacin with polar lipids helps hair growth and improves hair loss in women.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

One supplement improved hair loss and quality faster and more effectively than the other in treating telogen effluvium.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.